Immunosuppression and COVID-19 Boosters

Abroad (travel likely)RecruitingPHASE3

Conditions

COVID-19

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Blacktown Hospital, Blacktown, New South Wales, Australia
Contact: Study coordinator (Golo Ahlenstiel, MD-PhD) · golo.ahlenstiel@health.nsw.gov.au
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Contact: Study coordinator (Frederick Lee, PhD) · frederick.lee@health.nsw.gov.au
Concord General Repatriation Hospital, Concord, New South Wales, Australia
Contact: Study coordinator (Judith Trotman, MBChB) · judith.trotman@health.nsw.gov.au
St Vincent's Hospital, Sydney, Darlinghurst, New South Wales, Australia
Contact: Study coordinator (Anthony Kelleher, PhD) · akelleher@kirby.unsw.edu.au
Westmead Hospital, Westmead, New South Wales, Australia
Contact: Study coordinator (Sarah Sasson, PhD) · ssasson@kirby.unsw.edu.au

Study leads

Sarah C Sasson, PhD
Principal Investigator
The Kirby Institute UNSW Sydney

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Impact of COVID-19 on Maternal and Neonatal Outcomes

COVID-19 · Pregnancy; Infection

Abroad (travel likely)Recruiting

Baltimore, United States

Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Pathogen Infection Covid-19 Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

International Survey of Acute Coronavirus Syndromes-COVID-19

COVID-19

Abroad (travel likely)Recruiting

Bologna, Italy · Barcelona, Spain

Dime La VerDAD: Verify, Debunk, and Disseminate

Influenza · COVID-19 · Communication Research

Abroad (travel likely)Recruiting

Chicago, United States · Chicago, United States